Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (NY:ASX)

21.32 +0.43 (+2.06%)
Streaming Delayed Price Updated: 1:26 PM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ASE Technology Holding Co., Ltd. American Depositary Shares (each representing

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Alterity Therapeutics Enrolls First Patient in the United Kingdom in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Pushpay’s Annual State of Church Tech Report Shows Refined Use of Ministry Tools Among Catholic Churches
New results reveal the significant role that technology and digital solutions now play among parishes and diocese nationwide 
From Pushpay
Via GlobeNewswire
News headline image
5 Value Stocks In The Technology Sector ↗
 
Via Benzinga
News headline image
Earnings Preview: ASE Technology Holding Co ↗
 
Via Benzinga
Golden Cross Appears Before ASE Technology Holding Co Investors ↗
 
Via Benzinga
News headline image
ASE Technology Breaks Ground On New Chip Facility In Malaysia ↗
 
Via Benzinga
News headline image
Pushpay Announces New Product Innovations to Help Streamline Ministry Operations and Increase Engagement in the Church
From Pushpay
Via GlobeNewswire
News headline image
Alterity Therapeutics Enrolls First Patient in the U.S. in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
ASE Drives Latency and Bandwidth Innovation with VIPack™ Fanout Package-on-Package
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
News headline image
ASE Technology Clocks 25% Net Revenue Growth In Q3 Backed By ATM, EMS ↗
 
Via Benzinga
News headline image
Alterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer’s Disease
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Pushpay’s Customer Success Team Wins Contact Center of the Year at the 2023 Stevie® Awards
Pushpay was recognized among three categories at the 17th annual Stevie® Awards for Sales and Customer Success 
From Pushpay
Via GlobeNewswire
News headline image
Alterity Therapeutics Enrolls First Patient in Italy in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Pushpay’s 2023 State of Technology Report Reveals Hybrid Church Is Here to Stay
Research surfaces the powerful role technology and digital solutions play in the faith sector today, and future aspirations of the Church 
From Pushpay
Via GlobeNewswire
News headline image
Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to Commercialize VAZKEPA® (Icosapent Ethyl) in Australia and New Zealand
From Amarin Corporation plc
Via GlobeNewswire
News headline image
uniQure Announces HOPE-B Clinical Trial Data Published in the New England Journal of Medicine, Demonstrating Durability and Other Benefits of HEMGENIX® (etranacogene dezaparvovec-drlb)
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure announces the European Commission approval of the first gene therapy for adults with hemophilia B
From uniQure Inc.
Via GlobeNewswire
News headline image
Alterity Therapeutics Receives Regulatory Authorization in France and Austria to Proceed with ATH434 Phase 2 Clinical Trial
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Pushpay’s Women’s Leadership Exploration and Development Group to Host Public Event on International Women’s Day
“Bold Careers: Women Executives Discuss Their Authentic Journey” 
From Pushpay
Via GlobeNewswire
News headline image
Alterity’s ATH434 Prevents Loss of Brain Cells in Parkinson’s Disease Animal Model
Independent Study Reports ATH434 Prevented Onset of Motor and Non-Motor Symptoms in Animals with Genetically Induced Parkinson’s disease 
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Italy for the Treatment of Individuals with Multiple System Atrophy
Recruitment ongoing in Europe, Asia-Pacific, and the U.S. for study of rapidly progressive Parkinsonian Disorder 
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
7 Top-Rated Chip Stocks for Your January Must-Buy List ↗
Even as recession and 'tech slowdown' worries loom, now's the time to pounce on these seven chip-stocks to buy. 
Via InvestorPlace
News headline image
ASE’s Bumping Factory in Kaohsiung, Taiwan inducted into the World Economic Forum’s Global Lighthouse Network
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
News headline image
ASE Technology Holding Achieves the Best Overall Performance on the Dow Jones Sustainability Indices, Semiconductors and Semi Equipment Industry Group
From ASE Technology Holding Co., Ltd.
Via Business Wire
News headline image
NOVONIX to Participate in OTC Markets’ Small Cap Growth Virtual Investor Conference
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
ASE Breaks Ground on New Chip Assembly and Testing Facility in Penang, Malaysia
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
News headline image
Uranium Virtual Investor Conference: Presentations Now Available for On-Demand Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2022
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Lotus Resources to Webcast Live at VirtualInvestorConferences.com November 8th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
ASE announces FOCoS advancements under the VIPack™ Platform
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.